Artivion | CRY - Operating Profit


Artivion reported $4.79M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Integra LifeSciences USD 66M 54.24M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD 58K 5.7M Jun/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025